share_log

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Huntsman Ronald Kirk

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Huntsman Ronald Kirk

Vivos Therapeutics | 4:持股變動聲明-高管 Huntsman Ronald Kirk
美股sec公告 ·  06/28 20:57
Moomoo AI 已提取核心訊息
Ronald Kirk Huntsman, the Chief Executive Officer of Vivos Therapeutics, Inc. [VVOS], has been reported to hold a total of 73,061 shares in the company following recent transactions. The transactions, which took place on June 20, 2024, involved common stock and resulted in Huntsman holding 3,461 shares directly and 69,600 shares indirectly. The nature of the indirect ownership is detailed in a footnote, which is not disclosed in this summary. The report emphasizes the CEO's continued investment in the company's stock, which could be of interest to current and potential investors.
Ronald Kirk Huntsman, the Chief Executive Officer of Vivos Therapeutics, Inc. [VVOS], has been reported to hold a total of 73,061 shares in the company following recent transactions. The transactions, which took place on June 20, 2024, involved common stock and resulted in Huntsman holding 3,461 shares directly and 69,600 shares indirectly. The nature of the indirect ownership is detailed in a footnote, which is not disclosed in this summary. The report emphasizes the CEO's continued investment in the company's stock, which could be of interest to current and potential investors.
維沃斯治療公司(Vivos Therapeutics, Inc. [VVOS])首席執行官羅納德·柯克·亨斯邁(Ronald Kirk Huntsman)在最近的交易中持有總計73,061股公司股票。這些交易發生在2024年6月20日,包括普通股,導致亨斯邁直接持有3,461股,間接持有69,600股。這種間接持有權的性質在腳註中有詳細說明,但不在本摘要中披露。報告強調了首席執行官在公司股票中持續投資的情況,這可能對當前和潛在的投資者感興趣。
維沃斯治療公司(Vivos Therapeutics, Inc. [VVOS])首席執行官羅納德·柯克·亨斯邁(Ronald Kirk Huntsman)在最近的交易中持有總計73,061股公司股票。這些交易發生在2024年6月20日,包括普通股,導致亨斯邁直接持有3,461股,間接持有69,600股。這種間接持有權的性質在腳註中有詳細說明,但不在本摘要中披露。報告強調了首席執行官在公司股票中持續投資的情況,這可能對當前和潛在的投資者感興趣。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息